awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55317203-146C0A51-E171-4641-8998-242BF71E588C
Q55317203-146C0A51-E171-4641-8998-242BF71E588C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55317203-146C0A51-E171-4641-8998-242BF71E588C
Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells.
P2860
Q55317203-146C0A51-E171-4641-8998-242BF71E588C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55317203-146C0A51-E171-4641-8998-242BF71E588C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e77e64ab477e9d9eb4adf34e47554e93e8d9813d
P2860
Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer an